Atomic Capital Kicks off Investor Forum Announcing Digital Offering for NASDAQ-Traded Biotech Group, Agenus Inc.
NEW YORK, Jan. 29, 2019 /PRNewswire/ -- At a gathering of institutional investors this morning, Atomic Capital and Agenus Inc (NASDAQ: AGEN), announced the launch of a groundbreaking digital securities offering enabling the direct participation of accredited investors in Agenus' lead immuno-oncology asset. The proceeds from the digital securities offering, the first conducted by a publicly-traded company, will go to fund product development through FDA approval and commercialization, of the asset, with returns to investors backed by future product sales.
SYDNEY, January 29, 2019 /PRNewswire/ --
NEW YORK, Jan. 28, 2019 /PRNewswire/ --
Spruce Point Capital Releases A Strong Sell Forensic Research Opinion On Amdocs Limited (Nasdaq: DOX)
NEW YORK, Jan. 23, 2019 /PRNewswire/ -- Report entitled "Re-DOX of Dot.com Stock Collapse?" outlines how DOX faces 25%-50% intermediate downside risk to approximately $30 to $45 per share as a result of flat to negative organic growth, increasing limitations to M&A, growing evidence of cost capitalization and other aggressive accounting, and clear signs that executives are cashing out.
BlueMountain Capital Management, LLC Delivers Second Open Letter to Board of Directors of PG&E Corporation (NYSE: PCG) & Board of Directors of Pacific Gas and Electric Company
NEW YORK, Jan. 22, 2019 /PRNewswire/ -- BlueMountain Capital Management, LLC ("BlueMountain"), a private diversified alternative asset management firm, today sent an open letter to the Board of Directors of PG&E Corporation and the Board of Directors of Pacific Gas and Electric Company urging them to delay plans to file for Chapter 11 until at least after the annual shareholder meeting slated for May 21.